Rolfe M, James N H, Roberts R A
Zeneca Central Toxicology Laboratory, Alderley Park, Macclesfield, UK.
Carcinogenesis. 1997 Nov;18(11):2277-80. doi: 10.1093/carcin/18.11.2277.
Peroxisome proliferators (PPs) are a class of non-genotoxic rodent hepatocarcinogens that cause increased hepatocyte DNA synthesis, peroxisome proliferation and liver enlargement. We have demonstrated previously that PPs suppress both spontaneous rat hepatocyte apoptosis and that induced by the physiological negative regulator of liver growth, transforming growth factor beta (TGF beta1). Evidence suggests that the suppression of apoptosis by PPs is mediated via activation of the peroxisome proliferator activated receptor-alpha (PPAR alpha), a member of the nuclear hormone receptor superfamily. Here, we investigate the effects of tumour necrosis factor alpha (TNF alpha) on cultured rat or mouse hepatocytes to determine whether TNF alpha influences hepatocyte growth in a manner analogous to that seen with PPs. Rat recombinant TNF alpha was found to stimulate DNA synthesis and suppress apoptosis in isolated rat hepatocyte monolayers (P < or = 0.01). These effects were seen in the range of 500-5000 U/ml with a maximum effect at 5000 U/ml. Similarly, mouse recombinant TNF alpha was able to stimulate DNA synthesis in mouse hepatocyte monolayers (P < or = 0.01) with a maximal effect at 1000 U/ml. Suppression of mouse hepatocyte apoptosis by TNF alpha was not detected, possibly because of the low levels of apoptosis under control conditions. However, when the levels of mouse hepatocyte apoptosis were augmented using TGF beta1, TNF alpha caused a significant suppression (P < or = 0.01). The neutralization of TNF alpha using anti-TNF alpha antibodies abrogated significantly (P < or = 0.01) the suppression of apoptosis by the PP, nafenopin. These data that suggest TNF alpha may mediate, at least in part, the growth perturbation, liver enlargement and hepatocarcinogenesis seen in response to the PP class of non-genotoxic hepatocarcinogens.
过氧化物酶体增殖剂(PPs)是一类非遗传毒性啮齿动物肝癌致癌物,可导致肝细胞DNA合成增加、过氧化物酶体增殖和肝脏肿大。我们之前已经证明,PPs既能抑制大鼠肝细胞的自发性凋亡,也能抑制由肝脏生长的生理负调节因子转化生长因子β(TGFβ1)诱导的凋亡。有证据表明,PPs对凋亡的抑制作用是通过激活过氧化物酶体增殖物激活受体α(PPARα)介导的,PPARα是核激素受体超家族的成员。在此,我们研究肿瘤坏死因子α(TNFα)对培养的大鼠或小鼠肝细胞的影响,以确定TNFα是否以类似于PPs的方式影响肝细胞生长。发现大鼠重组TNFα能刺激分离的大鼠肝细胞单层中的DNA合成并抑制凋亡(P≤0.01)。在浓度为500 - 5000 U/ml范围内可观察到这些效应,在5000 U/ml时效果最佳。同样,小鼠重组TNFα能够刺激小鼠肝细胞单层中的DNA合成(P≤0.01),在1000 U/ml时效果最佳。未检测到TNFα对小鼠肝细胞凋亡的抑制作用,可能是因为对照条件下凋亡水平较低。然而,当使用TGFβ1提高小鼠肝细胞凋亡水平时,TNFα可导致显著抑制(P≤0.01)。使用抗TNFα抗体中和TNFα可显著消除(P≤0.01)PP萘芬诺平对凋亡的抑制作用。这些数据表明,TNFα可能至少部分介导了对非遗传毒性肝癌致癌物PP类所产生的生长紊乱、肝脏肿大和肝癌发生。